Atrys Health, S.A. (BME:ATRY)
2.870
+0.020 (0.70%)
Apr 24, 2025, 5:35 PM CET
Atrys Health Revenue
In the year 2024, Atrys Health had annual revenue of 218.10M EUR with 5.82% growth. Atrys Health had revenue of 108.74M in the half year ending December 31, 2024.
Revenue
218.10M
Revenue Growth
+5.82%
P/S Ratio
0.99
Revenue / Employee
118.47K
Employees
2,045
Market Cap
216.37M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 218.10M | 12.00M | 5.82% |
Dec 31, 2023 | 206.10M | 42.90M | 26.28% |
Dec 31, 2022 | 163.20M | 39.35M | 31.77% |
Dec 31, 2021 | 123.85M | 90.04M | 266.34% |
Dec 31, 2020 | 33.81M | 17.15M | 102.95% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Grifols | 7.21B |
Laboratorios Farmaceuticos Rovi | 763.75M |
Almirall | 990.63M |
Pharma Mar | 174.86M |
Faes Farma | 510.04M |
Clínica Baviera | 265.72M |
Laboratorio Reig Jofre | 338.90M |
Oryzon Genomics | 7.36M |